These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

243 related articles for article (PubMed ID: 27438868)

  • 1. Hearing and Vestibular Function After Preoperative Intratympanic Gentamicin Therapy for Vestibular Schwanomma as Part of Vestibular Prehab.
    Tjernström F; Fransson PA; Kahlon B; Karlberg M; Lindberg S; Siesjö P; Magnusson M
    Ear Hear; 2016; 37(6):744-750. PubMed ID: 27438868
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Preoperative vestibular ablation with gentamicin and vestibular 'prehab' enhance postoperative recovery after surgery for pontine angle tumours--first report.
    Magnusson M; Kahlon B; Karlberg M; Lindberg S; Siesjö P
    Acta Otolaryngol; 2007 Dec; 127(12):1236-40. PubMed ID: 17917842
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Auditory results after vestibular nerve section and intratympanic gentamicin for Ménière's disease.
    Colletti V; Carner M; Colletti L
    Otol Neurotol; 2007 Feb; 28(2):145-51. PubMed ID: 17255880
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intratympanic gentamicin for intractable Meniere's disease.
    Perez N; Martín E; García-Tapia R
    Laryngoscope; 2003 Mar; 113(3):456-64. PubMed ID: 12616197
    [TBL] [Abstract][Full Text] [Related]  

  • 5. PREHAB vs. REHAB - presurgical treatment in vestibular schwannoma surgery enhances recovery of postural control better than postoperative rehabilitation: Retrospective case series.
    Tjernström F; Fransson PA; Kahlon B; Karlberg M; Lindberg S; Siesjö P; Magnusson M
    J Vestib Res; 2018; 27(5-6):313-325. PubMed ID: 29400686
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effect of intratympanic gentamicin for treatment of Ménière's disease on lower frequency hearing.
    Sam G; Chung DW; van der Hoeven R; Verweij S; Becker M
    Int J Clin Pharm; 2016 Aug; 38(4):780-3. PubMed ID: 27073077
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Vestibular nerve section versus intratympanic gentamicin for Meniere's disease.
    Hillman TA; Chen DA; Arriaga MA
    Laryngoscope; 2004 Feb; 114(2):216-22. PubMed ID: 14755193
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intratympanic gentamicin for control of vertigo in Meniere's disease: vestibular signs that specify completion of therapy.
    Minor LB
    Am J Otol; 1999 Mar; 20(2):209-19. PubMed ID: 10100525
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Single-shot, low-dose intratympanic gentamicin in Ménière disease: role of vestibular-evoked myogenic potentials and caloric test in the prediction of outcome.
    Gode S; Celebisoy N; Akyuz A; Gulec F; Karapolat H; Bilgen C; Kirazli T
    Am J Otolaryngol; 2011; 32(5):412-6. PubMed ID: 20851502
    [TBL] [Abstract][Full Text] [Related]  

  • 10. 'PREHAB': Vestibular prehabilitation to ameliorate the effect of a sudden vestibular loss.
    Magnusson M; Karlberg M; Tjernström F
    NeuroRehabilitation; 2011; 29(2):153-6. PubMed ID: 22027076
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Gentamicin perfusion vestibular response and hearing loss.
    Light JP; Silverstein H; Jackson LE
    Otol Neurotol; 2003 Mar; 24(2):294-8. PubMed ID: 12621347
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cervical vestibular-evoked myogenic potential in vestibular schwannoma after gamma-knife surgery.
    Lee YF; Lee CC; Wang MC; Liu KD; Wu HM; Guo WY; Shiao AS; Pan DH; Chung WY; Hsu SP
    Auris Nasus Larynx; 2015 Aug; 42(4):265-70. PubMed ID: 25666552
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Distortion product otoacoustic emissions after intratympanic gentamicin therapy for unilateral Ménière's disease.
    Perez N; Boleas MS; Martin E
    Audiol Neurootol; 2005; 10(2):69-78. PubMed ID: 15650298
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Refractory episodic vertigo: role of intratympanic gentamicin and vestibular evoked myogenic potentials.
    Celis-Aguilar E; Hinojosa-González R; Vales-Hidalgo O; Coutinho-Toledo H
    Braz J Otorhinolaryngol; 2016; 82(6):668-673. PubMed ID: 27068887
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Gentamicin Applied to the Oval Window Suppresses Vestibular Function in Guinea Pigs.
    King EB; Shepherd RK; Brown DJ; Fallon JB
    J Assoc Res Otolaryngol; 2017 Apr; 18(2):291-299. PubMed ID: 28050646
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long-term hearing outcome in patients receiving intratympanic gentamicin for Ménière's disease.
    Wu IC; Minor LB
    Laryngoscope; 2003 May; 113(5):815-20. PubMed ID: 12792316
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Preoperative Differences in Intracranial Facial Versus Vestibular Schwannomas: A Four Nerve Assessment.
    Erbele ID; Klumpp ML; Arriaga MA
    Laryngoscope; 2021 Sep; 131(9):2098-2105. PubMed ID: 34013983
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intratympanic Gentamicin for Small Vestibular Schwannomas With Intractable Vertigo.
    Yang J; Jia H; Li G; Huang M; Zhu W; Wang Z; Li Y; Wu H
    Otol Neurotol; 2018 Sep; 39(8):e699-e703. PubMed ID: 30020264
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intratympanic gentamicin therapy for intractable Ménière's disease.
    De Beer L; Stokroos R; Kingma H
    Acta Otolaryngol; 2007 Jun; 127(6):605-12. PubMed ID: 17503229
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The use of intratympanic gentamicin in patients with vestibular schwannoma and disabling vertigo.
    Giannuzzi AL; Merkus P; Falcioni M
    Otol Neurotol; 2013 Aug; 34(6):1096-8. PubMed ID: 23370568
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.